Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines.
Melisa J Baptista; Casey O'Farrell; Sneha Daya; Rili Ahmad; David W Miller; John Hardy; Matthew J Farrer; Mark R Cookson (Profiled Author: Hardy, John)
Laboratory of Neurogenetics, National Institute on Aging/NIH, Building 10 Room 6C103, MSC 1589, 9000 Rockville Pike, Bethesda, MD 20892, USA. baptista@mail.nih.gov
Journal of neurochemistry 2003;85(4):957-68.
Abnormal accumulation of alpha-synuclein in Lewy bodies is a neuropathological hallmark of both sporadic and familial Parkinson's disease (PD). Although mutations in alpha-synuclein have been identified in autosomal dominant PD, the mechanism by which dopaminergic cell death occurs remains unknown. We investigated transcriptional changes in neuroblastoma cell lines transfected with either normal or mutant (A30P or A53T) alpha-synuclein using microarrays, with confirmation of selected genes by quantitative RT-PCR. Gene products whose expression was found to be significantly altered included members of diverse functional groups such as stress response, transcription regulators, apoptosis-inducing molecules, transcription factors and membrane-bound proteins. We also found evidence of altered expression of dihydropteridine reductase, which indirectly regulates the synthesis of dopamine. Because of the importance of dopamine in PD, we investigated the expression of all the known genes in dopamine synthesis. We found co-ordinated downregulation of mRNA for GTP cyclohydrolase, sepiapterin reductase (SR), tyrosine hydroxylase (TH) and aromatic acid decarboxylase by wild-type but not mutant alpha-synuclein. These were confirmed at the protein level for SR and TH. Reduced expression of the orphan nuclear receptor Nurr1 was also noted, suggesting that the co-ordinate regulation of dopamine synthesis is regulated through this transcription factor.
3 Originating Grant
-
1.
Hardy, John A
GENETICS AND MOLECULAR BIOLOGY OF PARKINSONISM
30 September 1999 - 31 July 2004
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 3,886,270
-
2.
Dickson, Dennis William
Genetics and Molecular Biology of Parkinsonism
30 September 1999 - 31 August 2009
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 8,904,777
-
3.
Dickson, Dennis W
GENETICS AND MOLECULAR BIOLOGY OF PARKINSONISM
30 September 1999 - 29 September 2004
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 2,454,521
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
Lansbury, Peter T
Discovery of highly toxic synuclein sequence variants
1 April 2005 - 31 March 2007
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 172,694
-
2.
Rogers, Jack T
RNA Targeted Screens of the Prion 5'UTR
30 September 2008 - 31 August 2010
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 269,917
-
3.
Lansbury, Peter T
Familial Parkinson's Disease: Clues to Pathogenesis
1 August 2000 - 31 August 2010
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Total Funding: $ 16,380,885
Related Publications
-
1.
2006Yaping Chu; Weidong Le; Katie Kompoliti; Joseph Jankovic; Elliott J Mufson; Jeffrey H Kordower
Nurr1 in Parkinson's disease and related disorders.
The Journal of comparative neurology 2006;494(3):495-514. -
2.
2001S Rathke-Hartlieb; P J Kahle; M Neumann; L Ozmen; S Haid; M Okochi; C Haass; J B Schulz
Journal of neurochemistry 2001;77(4):1181-4. -
3.
2000E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Science (New York, N.Y.) 2000;287(5456):1265-9.

Appears in this Publication







